Evidence map›Paper›PMID 41476773›Full record

ArticleBiochemistry and biophysics reports2026

Methodological validation of a cryo-TEM-based detection method for empty capsid ratio in recombinant adeno-associated virus.

Lingyi Xu, Jinhuan Chen, Wei Zhu, Yaokun Zhao, Fangfang Zheng, Rong Du, Yuwei Jiang, Yidan Yang, Yuanyuan Chen, Yuanshu Dong and 2 more

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lingyi XuWuXi Biologics Biosafety Testing (Shanghai) Co., Ltd, Shanghai, China.
Jinhuan ChenWuXi Biologics Biosafety Testing (Shanghai) Co., Ltd, Shanghai, China.
Wei ZhuWuXi Biologics Biosafety Testing (Shanghai) Co., Ltd, Shanghai, China.
Yaokun ZhaoWuXi Biologics Biosafety Testing (Shanghai) Co., Ltd, Shanghai, China.
Fangfang ZhengWuXi Biologics Biosafety Testing (Shanghai) Co., Ltd, Shanghai, China.
Rong DuWuXi Biologics Biosafety Testing (Shanghai) Co., Ltd, Shanghai, China.
Yuwei JiangWuXi Biologics Biosafety Testing (Shanghai) Co., Ltd, Shanghai, China.
Yidan YangWuXi Biologics Biosafety Testing (Shanghai) Co., Ltd, Shanghai, China.
Yuanyuan ChenWuXi Biologics Biosafety Testing (Suzhou) Co., Ltd, Suzhou, China.
Yuanshu DongWuXi Biologics Biosafety Testing (Suzhou) Co., Ltd, Suzhou, China.
Zhengxi ZhangWuXi Biologics Biosafety Testing (Shanghai) Co., Ltd, Shanghai, China.
Yong TongWuXi Biologics Biosafety Testing (Suzhou) Co., Ltd, Suzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recombinant adeno-associated virus (rAAV) is one of the most promising vectors for gene therapy. It consists of a protein capsid that encapsulates the genetic material. However, during the production process, except for the full particles containing the genome, a variety of types of particles are also produced concomitantly, such as empty particles (no DNA encapsulated in the capsid), viral fragments, damaged viruses, and viral aggregates. Empty particles have been reported to induce unnecessary immune response and reduce transduction efficiency. Therefore, a quantitative method that objectively assesses the content of rAAV particles containing the genome is crucial for quality measurement. In this study, we developed a technique to detect the proportion of empty capsids in rAAV samples by using cryogenic transmission electron microscopy (cryo-TEM). This method not only accurately quantifies the percentage of empty capsids, but also allows for the characterization and analysis of other different particle types within the sample. Our comprehensive evaluation of specificity, precision, accuracy, linearity, and limit of quantitation (LOQ) demonstrates the advantages of cryo-TEM technology for the quantitative analysis of rAAV empty capsid ratio. Moreover, this research offers a thorough, multidimensional approach to enhance the understanding and implementation of quality control for rAAV.

Indexed as

Cryo-TEMEmpty capsid ratioMethodological validationrAAV

Identifiers

PMID41476773
PMCPMC12750778

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.